FURIEX PHARMACEUTICALS INC's ticker is FURX and the CUSIP is 36106P101. A total of 92 filers reported holding FURIEX PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 5,860.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $2,334,000 | +27.1% | 21,978 | +4.1% | 0.00% | +33.3% |
| Q1 2014 | $1,837,000 | +124.8% | 21,106 | +8.6% | 0.00% | +50.0% |
| Q4 2013 | $817,000 | -2.9% | 19,426 | +3.1% | 0.00% | 0.0% |
| Q3 2013 | $841,000 | +37.4% | 18,850 | +10.8% | 0.00% | +100.0% |
| Q2 2013 | $612,000 | – | 17,018 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Magnetar Financial LLC | 950,000 | $100,871,000 | 1.68% |
| Camber Capital Management LP | 200,000 | $21,236,000 | 1.39% |
| OXFORD ASSET MANAGEMENT LLP | 378,901 | $40,080,000 | 1.30% |
| Magnetar Financial LLC | 734,006 | $77,937,000 | 1.30% |
| HARVEST MANAGEMENT LLC | 10,077 | $1,070,000 | 1.08% |
| FRANKLIN STREET ADVISORS INC /NC | 48,755 | $5,177,000 | 0.99% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 251,319 | $26,685,000 | 0.78% |
| Biondo Investment Advisors, LLC | 19,385 | $2,058,000 | 0.65% |
| Andromeda Capital LLC | 75,100 | $7,974,000 | 0.56% |
| CSS LLC/IL | 126,200 | $13,399,000 | 0.56% |